4
Changes in Ownership
ARROWHEAD PHARMACEUTICALS, INC. Filed Acc 0001209191-22-001323
Director sold 4,500 shares at an average $64.71 ($291,177)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| De Backer Marianne Director | 2022-01-03 | Sale | −2,244 | $64.25 | $144,177 | 19,256 | D: show line 1 in the form |
| De Backer Marianne Director | 2022-01-03 | Sale | −1,984 | $65.01 | $128,980 | 17,272 | D: show line 2 in the form |
| De Backer Marianne Director | 2022-01-03 | Sale | −272 | $66.25 | $18,020 | 17,000 | D: show line 3 in the form |
| Open-market sales · 4,500 sh · avg $64.71 · $291,177 | |||||||
Loading xslF345X03/doc4.xml…